Tesla (TSLA) opened its 'Semi' truck production facility, but faces regulatory and legal headwinds, alongside thin net profit margins and minimal free cash flow.
Source Post
5 Stocks, 5 Catalysts: KOD, NVDA, Tesla, SpaceX & AMD | Sept 29, 2026
Sep 29, 2026
This podcast episode discusses five companies: Kodiak Sciences (KOD), Nvidia (NVDA), Tesla (TSLA), SpaceX (SPCE), and AMD. For KOD, the focus is on positive clinical trial results for a wet AMD treatment and the associated funding risks. NVDA's discussion highlights its exceptional financial performance and a significant increase in long-term debt. TSLA's new "Semi" truck facility and upcoming delivery reports are covered, alongside financial pressures. SpaceX's successful Starship orbital flight and NASA contract extension are noted. AMD is mentioned as the final company, though its specific details are not yet provided in this chunk.
Linked Mentions
Tickers discussed in this post
Nvidia (NVDA) shows extraordinary financial results with high margins, but a significant increase in long-term debt warrants close monitoring.
Kodiak Sciences (KOD) reported positive Phase 3 trial results for its wet AMD treatment, but faces significant funding risks as it moves towards regulatory approval.
Linked Signals
Tracked calls opened from this post
No linked signals were opened directly from this post.